# Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy

> **NCT00490061** · PHASE2 · TERMINATED · sponsor: **Quynh-Thu Le** · enrollment: 17 (actual)

## Conditions studied

- Head and Neck Cancer
- Carcinoma, Squamous Cell
- Head and Neck Cancers

## Interventions

- **DRUG:** Lapatinib
- **PROCEDURE:** Radiotherapy (radiation)
- **DEVICE:** G.E. Healthcare 1.5T MR, systems revision 12.0 M5
- **DEVICE:** DCE-MRI

## Key facts

- **NCT ID:** NCT00490061
- **Lead sponsor:** Quynh-Thu Le
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2013-01
- **Final completion:** 2016-06
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Poor accrual.
- **Last updated:** 2017-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00490061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00490061, "Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00490061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*